title: Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis.
abstract: There has been no systematic study of the immune response of individuals aged over 60 years living in Schistosomiasis mansoni-endemic areas, although senescence is reportedly associated with susceptibility to infection and progressive decline in immune function. We have shown previously, in two endemic areas in Minas Gerais, Brazil, that the frequency of individuals aged over 60 years with chronic schistosomiasis is no longer negligible. Moreover, several elderly individuals who have always lived in these endemic areas stay protected from infection. An important question for studies of ageing and disease control in developing countries is which differences in the immunological profile of these negatively tested (non-infected) individuals can account for their resistance to either infection or reinfection. We show, in the present study, that non-infected (negative) elderly individuals develop innate immune mechanisms of protection that replace the age-associated decline in T cell function. Non-infected elderly individuals from endemic areas of schistosome infection present an increase in the frequency of the natural killer (NK) CD56(low) subset of NK cells expressing Toll-like receptors (TLR)-1, -2, -3 and -4 as determined by flow cytometry analysis. In addition, the proportion of dendritic cells expressing TLR-1 is elevated as well as the frequency of monocytes expressing TLR-1 and -4. These results suggest that TLR expression by cells of the innate immune system may be related to the negative status of infection in some elderly individuals who are constantly exposed to S. mansoni. Developing mechanisms of protection from infection may represent a biomarker for healthy ageing in this population.
authors.affiliation: Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
authors.forename: F
authors.initials: F
authors.lastname: Comin
authors.forename: E
authors.initials: E
authors.lastname: Speziali
authors.forename: O A
authors.initials: OA
authors.lastname: Martins-Filho
authors.forename: I R
authors.initials: IR
authors.lastname: Caldas
authors.forename: V
authors.initials: V
authors.lastname: Moura
authors.forename: A
authors.initials: A
authors.lastname: Gazzinelli
authors.forename: R
authors.initials: R
authors.lastname: Correa-Oliveira
authors.forename: A M C
authors.initials: AM
authors.lastname: Faria
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000276:immunology*; D001938:Brazil / Q000453:epidemiology; D019002:CD56 Antigen / Q000097:blood; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D003713:Dendritic Cells / Q000276:immunology; D019353:Endemic Diseases; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology; D012555:Schistosomiasis mansoni / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D051193:Toll-Like Receptors / Q000097:blood*; D015854:Up-Regulation / Q000276:immunology
chemical_list: D019002:CD56 Antigen; D051193:Toll-Like Receptors